Check Cap

Check Cap EPS Growth

The EPS Growth of Check Cap (MBAI) as of Oct 9, 2026 is 208.18 %. In the previous year, EPS Growth was -46.80 % — a change of -544.84% (higher).

EPS Growth

208.18 %

YoY

-544.84%

Last updated:

EPS Growth of Check Cap is 2025 208.18 % . EPS Growth of Check Cap was 2024 -46.80 % . It decreases by -544.84% higher compared to the previous year.

The Check Cap EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2022
25.95 USD
Jan 1, 2023
8.06 USD
Jan 1, 2024
-46.80 USD
Jan 1, 2025
208.18 USD
The Check Cap EPS Growth history
YEAREPS GrowthYoY
208.18 %-544.84%
-46.80 %-680.69%
8.06 %-68.94%
25.95 %—
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

EPS Growth of Check Cap is 208.18 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Check Cap since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Check Cap historically and in real time.

Access this data via the Eulerpool API

Growth — Check Cap

All Key Metrics — Check Cap